JEANETTE BANNISTER: Open Payments
NPI 1427325638 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 19 payments from 10 companies in 2025. Trend: 2023 $277 · 2024 $629 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $103 |
| Galderma Laboratories, L.P. | 3 | $70 |
| Amgen Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $46 |
| Almirall LLC | 2 | $41 |
| GENZYME CORPORATION | 1 | $35 |
| UCB, Inc. | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Organon LLC | 1 | $14 |
Products named: TALTZ, NEMLUVIO, Otezla, SKYRIZI, Klisyri, DUPIXENT, Bimzelx, TREMFYA.
Industry payments across AZ — which companies pay providers there.
